PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 4/28

PharmD_KS's avatar
PharmD_KS
Apr 27, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The 2026 Equity Markets Year Ahead can be watched here: 2026 Equity Markets Year Ahead

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 4/26

I launched a new service offering that can be seen here on X: Doggy Style Daily Degeneracy

The market was rather quiet today, but the trade setups were super clean. It was a “one and done” kind of day as it often is in a persistent uptrend.

The planned A+ trade was a hold or look below and fail of 7177-7182 on ES. It played out overnight as a LBAF (low of night 7171.5) resolving to the weekly 7206-7211 level (7208.5 overnight high) pretty early in the overnight session. This then triggered a pullback which held the 7177-7182 level 3 times including today’s low at 7177. This also produced a LBAF of the IB low which only improved the setup, and it resolved back to the 7206-7211 weekly level (7211.25 high of day).

NQ was a similar trade but played out in the opposite manner as it held the key level overnight, and then saw a LBAF during cash hours. It maintained some relative weakness after its selloff from the overnight high. This gave the overnight trade a lot more range (and frankly would have been much easier to hold) as it rallied nearly 200 handles in a straight line.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture